MedTrace Logo

Pupillary Response After Glaucoma Medication

NCT02522039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2015-08-13

No results posted yet for this study

Summary

Investigation of the effect on the pupillary constriction by latanoprost, dorzolamide,timolol in healthy subjects. The pupillary constriction is compared to no drug.

Conditions

  • Drug Effect (Glaucoma Drugs)

Interventions

DRUG

Latanoprost

1 drop of latanoprost was given to study eye after washout period of 1 week between drugs

DRUG

Timolol

1 drop of timolol was given to study eye after washout period of 1 week between drugs

DRUG

Dorzolamide

1 drop of dorzolamide was given to study eye after washout period of 1 week between drugs

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Henrik Lund-Andersen, Professor · Head of the project

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522039 on ClinicalTrials.gov